Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ALSN
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.59 2.51 2.50
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -5.14 7.04 7.42
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 10.08 15.25 13.85
Cash 0.96 6.38 6.31
Capex 78.60 -0.13 -0.58
Free Cash Flow -11.91 1.84 2.09
Revenue 2.97 8.97 8.71
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -1.23 0.46 0.46
Operating Margin 2.15 0.30 0.29
ROA -1.20 0.03 0.03
ROE -8.66 0.13 0.14
ROIC 4.12 0.05 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ALSN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ALSN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ALSN is permitted for members.